Laurion Capital Management
HCAT icon

Laurion Capital Management’s Health Catalyst HCAT Stock Holding History

Laurion Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-136,318
Closed -$5.93M – 805
2020
Q4 		$5.93M Buy
+136,318
New +$5.03M 0.05% 228
2019
Q4 		– Sell
-50,000
Closed -$1.58M – 1012
2019
Q3 		$1.58M Buy
+50,000
New +$1.97M 0.01% 549

Other funds holding HCAT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Riverbridge Partners
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Laurion Capital Management's HCAT Position: Q1 2021 in Review

Laurion Capital Management sold out of Health Catalyst (HCAT) in Q1 2021, closing a stake of 136,318 shares — an estimated $5.93M sold.

Laurion Capital Management first reported a position in HCAT in Q3 2019 and held it in 2 quarters. The position peaked at $5.93M in Q4 2020. 190 funds tracked by Wall St. Rank hold HCAT as of Q1 2021.

  • Laurion Capital Management reported no remaining Health Catalyst position as of Q1 2021 after selling out during the quarter.
  • Laurion Capital Management sold 136,318 Health Catalyst shares in Q1 2021, an estimated $5.93M.
  • Laurion Capital Management first reported a position in Health Catalyst in Q3 2019 and held it in 2 quarters.
  • Laurion Capital Management's Health Catalyst position peaked at $5.93M in Q4 2020.
  • 190 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2021.

Based on Laurion Capital Management's 13F filing for Q1 2021, filed 14 May 2021.